A critical review of the use of carvedilol in ischemic heart disease.
about
Carvedilol decrease IL-1β and TNF-α, inhibits MMP-2, MMP-9, COX-2, and RANKL expression, and up-regulates OPG in a rat model of periodontitisEffects of carvedilol on structural and functional outcomes and plasma biomarkers in the mouse transverse aortic constriction heart failure model.Smad3 inactivation and MiR-29b upregulation mediate the effect of carvedilol on attenuating the acute myocardium infarction-induced myocardial fibrosis in rat.Combination of microRNA-21 and microRNA-146a Attenuates Cardiac Dysfunction and Apoptosis During Acute Myocardial Infarction in MiceCardioprotective effect of carvedilol: inhibition of apoptosis in H9c2 cardiomyocytes via the TLR4/NF-κB pathway following ischemia/reperfusion injury
P2860
A critical review of the use of carvedilol in ischemic heart disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
A critical review of the use of carvedilol in ischemic heart disease.
@en
type
label
A critical review of the use of carvedilol in ischemic heart disease.
@en
prefLabel
A critical review of the use of carvedilol in ischemic heart disease.
@en
P2093
P2860
P1476
A critical review of the use of carvedilol in ischemic heart disease.
@en
P2093
Carol Chen-Scarabelli
Giuseppe Faggian
Justin Di Rezze
Louis Saravolatz
Rodeo Abrencillo
Tiziano M Scarabelli
Tova Gardin
Umesh K Gidwani
Waqas Qureshi
Wen-Shi Shieh
P2860
P304
P356
10.2165/11636090-000000000-00000
P577
2012-12-01T00:00:00Z
P5875
P6179
1069132424